Insider transactions at MYR Group over the past year are not encouraging. The modest insider ownership offers some solace. Insider share selling, particularly below current price, may signal negative future prospects.
High interest rates and supply chain issues have hit the clean energy sector hard. However, companies like Nextracker, MYR Group, and Quanta Services, which facilitate clean energy projects without financing them, are thriving. Gentherm, an auto supply company, is also adapting well to the evolving electrical systems in cars.
MYR Group's ROCE rise and profitable capital reinvestment are positive. Yet, the growth in current liabilities is worrisome. The 392% stock return over five years shows investor optimism.
MYR Group's shares are still undervalued, indicating a potential buying opportunity. The company's future looks promising with expected higher cash flow, which should lead to a higher share valuation. The current share price does not fully capture the optimistic future outlook, suggesting it's not too late to buy MYRG.
Insider stock sales below current price imply a potentially concerning company valuation. Despite this discouraging sign, it's a weak signal. Modest 2.0% insider ownership shows some executive-shareholder alignment.
MYR Group's performance, backed by impressive ROE metrics and reinvestment of profits, has led to a healthy earnings growth. Analysts project future growth at similar rates.
MYR Group's successful reinvestment has garnered higher capital returns, yielding a striking 308% stock return in five years. Despite a promising future, significant current liabilities pose potential risks.
The sustained increase in the MYR Group stock price and improved total shareholder return in the past year may indicate business momentum, implying that the present could be a good time for potential investment in MYR Group.
MYR Group Stock Forum
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...
No comment yet